With dealmaking a cornerstone of the growth strategy, 2020 will
be a robust year for life sciences M&A. To succeed, companies
must continue to focus their business models, close near term
growth gaps and invest in future innovation.
About the Podcast
The rise of the empowered consumer, coupled with technology advancements and the emergence of digitally focused entrants, is changing every aspect of health and care delivery. To retain relevancy in today’s digitally focused, data-infused ecosystem, all participants in health care today must rethink their business practices, including capital strategy, partnering and the creation of patient-centric operating models. This series explores these challenges and opportunities